Activation of the endoplasmic reticulum stress sensor, IRE1α, is required for effective immune responses against bacterial infection and is associated with human inflammatory diseases where neutrophils are a key immune component. However, the specific role of IRE1α in regulating neutrophil effector function has not been studied.
Introduction
Neutrophils are critical first responders to infection, poised to rapidly kill invading pathogens with a dense array of secretory granules containing a diverse repertoire of antimicrobial molecules ( 1 , 2 ) . Neutrophils can kill intracellular microbes by concentrating these microbicides in phagosomes through fusion of secretory granules and generation of reactive oxygen species (ROS). These polymorphonuclear (PMN) leukocytes can also kill extracellular microbes by degranulation and exocytosis of secretory granules, releasing antimicrobial molecules into the extracellular space ( 3 ) .
Additionally, neutrophils secrete inflammatory chemokines and cytokines to recruit other immune cells to mediate a multi-pronged host defense against infection ( 4 ) .
Upon stimulation, neutrophils can release sticky web-like structures composed of genomic DNA and associated proteins, termed neutrophil extracellular traps (NETs) ( 5 ) .
NET formation is induced by a wide range of microbes, including bacteria, fungi, parasites and viruses ( 6 ) . During infection, neutrophils extrude NETs to trap microbes, likely limiting spread from the primary site of infection ( 7 , 8 ) . Preventing NET formation decreases the capacity of neutrophils to kill Gram-positive and Gram-negative bacteria ( 5 ) . NETs are enriched with neutrophil-derived granule enzymes like neutrophil elastase, myeloperoxidase, cathepsin G, and cathelicidins, defensins and other antimicrobial peptides ( 9 ) . Thus, NETs may aid in microbial killing directly by concentrating microbicidal molecules onto extracellular pathogens trapped in this structure. NETs are also linked to inflammatory diseases such as Systemic Lupus Erythematosus (SLE), psoriasis, or diabetes ( 10 , 11 ) . Exaggerated NET formation or defects in NET clearance can exacerbate these diseases ( 10 ) . Thus, NET formation must be highly regulated to promote host defense without resulting in pathological inflammatory consequences.
NET release requires generation of reactive oxygen species (ROS) and histone modification to promote decondensation of nuclear chromatin ( 12 , 13 ) . Several chemical and biological stimuli trigger ROS production and histone citrullination to promote NET formation, including phorbol 12-myristate 13-acetate (PMA), the calcium ionophore (A23187) and various microbial infections ( 6 , 14 , 15 ) . Notably, ROS that contribute to NET formation can be generated by multiple sources including the major phagocyte oxidase, NADPH oxidase 2 (NOX2) and mitochondria ( 14 , 16 , 17 ) . ROS induce translocation of granule proteins such as neutrophil elastase (NE) into the nucleus to promote chromatin relaxation by cleaving nucleosomal histones ( 18 ) . Concomitantly, histone citrullination by peptidylarginine deiminase-4 (PAD4) reduces net positive charge and decreases histone binding affinity for nuclear DNA, freeing DNA to be expelled from the cell ( 13 , 19 -21 ) . PAD4 requires calcium as a cofactor to become active, and localizes to the neutrophil nucleus upon stimulation ( 22 , 23 ) . Treating neutrophils with PAD4 inhibitors or preventing calcium mobilization suppresses NET formation ( 19 , 24 ) . PAD4-deficient neutrophils are unable to citrullinate histones, decondense chromatin and generate NETs, resulting in greater susceptibility to bacterial infection ( 20 ) . Neutrophils, as highly secretory cells, are dependent on optimal ER function. In general, perturbation of ER homeostasis triggers an adaptive stress response, termed the unfolded protein response (UPR), and is controlled by three resident ER sensors, of which the inositol-requiring enzyme 1-α (IRE1α) is the most evolutionarily conserved ( 25 ) . During ER stress, oligomerization of IRE1α triggers autophosphorylation and activation of its cytoplasmic endonuclease domain ( 26 , 27 ) . The endonuclease removes a 26-nucleotide intron from the cytoplasmic Xbp1 mRNA, licensing translation of the transcription factor X-box Binding Protein-1 (XBP1) ( 28 ) . XBP1 then induces expression of many genes that improve ER protein folding and degradation to restore ER homeostasis ( 29 , 30 ) . Activation of IRE1α in immune cells enhances production of many proinflammatory cytokines, such as IL-1β, IL-6, and TNFα ( 31 -33 ) . IRE1α is implicated in inflammation during infection and in many autoimmune diseases such as rheumatoid arthritis and systemic lupus erythematosus, where neutrophils and NET formation contribute to the progression of these diseases ( 10 , 34 ) .
We recently demonstrated that IRE1α aids in clearance of methicillin-resistant
Staphylococcus aureus (MRSA) in a subcutaneous abscess model, normally controlled by neutrophils and neutrophil-derived IL-1β ( 35 , 36 ) . However, the specific role of IRE1α in neutrophil function is poorly understood. Here we investigated the contribution of IRE1α to neutrophil antimicrobial function. We show that MRSA infection triggers neutrophil IRE1α activation, and find that this activation is required for efficient neutrophil killing of MRSA, production of IL-1β and NET formation. IRE1α promotes generation of mitochondrial ROS (mROS), activation of CASPASE-2 and intracellular calcium mobilization, all required for optimal neutrophil antimicrobial function. Moreover, Caspase-2 deficient mice infected with MRSA exhibited increased bacterial burden, lower levels of IL-1β, and failed to generate NETs in a subcutaneous abscess model compared to wild-type mice. Collectively, these data point to IRE1α as a positive regulator of neutrophil effector function, which is critical in coordinating the inflammatory response.
Results

Neutrophil IRE1α activation enhances MRSA killing and IL-1β production
To define the role of IRE1α in neutrophil host defense against bacterial infection, we first determined whether infection activates neutrophil IRE1α, using the clinically derived MRSA strain USA300 LAC. Human PMN were purified from blood of healthy volunteers as previously described ( 37 ) , yielding cell populations >95% CD15 + CD16 + , characteristic of neutrophils ( Fig. S1A ). Neutrophils incubated with MRSA showed increased levels of the spliced variant of XBP1 , indicating that IRE1α was activated ( Fig. 1A and B ). To determine the functional consequences of MRSA-induced IRE1α activation on neutrophil bactericidal activity and IL-1β production, we treated PMN with IRE1α inhibitors 4μ8C or KIRA6 ( 38 , 39 ) . In inhibitor-treated neutrophils, XBP1 splicing was substantially reduced (Fig. 1B ), and these cells were less capable of killing MRSA (Fig. 1C ). In addition, inhibitor-treated neutrophils produced lower levels of IL-1β ( Fig.  1D ) compared to controls. To determine whether these outcomes were due to drug toxicity on MRSA and/or neutrophils, we monitored effects of 4μ8C or KIRA6 on MRSA growth and neutrophil survival. Treatment with 4μ8C or KIRA6 did not affect either axenic growth of MRSA (Fig. S1 , B and C) or neutrophil cell viability (Fig. S1 , D and E).
These data demonstrate the requirement for IRE1α in neutrophil killing and IL-1β production upon MRSA infection.
NET formation depends on IRE1α activity during MRSA infection
Neutrophils form bactericidal extracellular traps (NETs) during Staphylococcus aureus infection ( 5 , 8 ) . NET formation is also driven by IL-1β production and signaling ( 40 , 41 ) .
Therefore, we investigated the role of IRE1α in NET formation stimulated by MRSA infection. Neutrophils were cultured on poly-lysine coated coverslips and infected with MRSA-GFP at a multiplicity of infection (MOI) of 10 for 4 hours in the presence and absence of IRE1α inhibitors. NET formation was assessed by immunofluorescence microscopy by measuring the extracellular co-localization of neutrophil elastase (NE) and DNA ( Fig. 1E ). Uninfected neutrophils predominantly had a multi-lobed nucleus and intracellular staining of NE, indicating that these cells did not form NETs. During MRSA infection, NE and DNA were observed extracellularly in many cells, while others lost the multi-lobed nucleus appearance, suggesting that these cells had undergone NETosis.
When neutrophils were treated with IRE1α inhibitor 4μ8C during MRSA infection, we observed lower levels of extracellular NE and DNA association compared to the DMSO control, indicating that IRE1α contributes to MRSA-induced NETosis. To quantify NETosis, we measured accumulation of extracellular DNA by using the cell- IL-1β signaling is required for NETosis during sterile inflammatory acute gout ( 40 ) . We therefore investigated whether IRE1α controls MRSA-induced NET formation via IL-1β signaling. Treatment of neutrophils with IL-1 receptor antagonist, IL-1RA, prior to MRSA infection did not decrease NET production, which was quantified by extracellular SYTOX Green fluorescence ( Fig. 1G ). Neutrophils stimulated with recombinant IL-1β in the presence or absence of IL-1RA and 4μ8C ( Fig. 1G ). Treatment of uninfected neutrophils with recombinant IL-1β, regardless of the presence of IL-1RA or 4μ8C, did not increase SYTOX fluorescence intensity compared to untreated neutrophils, indicating that IL-1β is not sufficient to cause neutrophils derived from healthy donors to undergo NETosis. Together, our data suggest that IRE1α promotes neutrophil NETosis in response to MRSA infection independently of IL-1β signaling.
Mitochondrial ROS contributes to IRE1α-dependent NET formation
NET formation occurs in an oxidant-dependent manner. NADPH oxidase 2 (NOX2) is a major complex for generation of reactive oxygen species (ROS) and is required for some stimuli-induced NET formation ( 16 ) . However, ROS production by mitochondria (mROS) is also important for NET formation during sterile inflammation and has been associated with NOX2-independent NETosis ( 14 , 17 ) . We recently showed that macrophage IRE1α induces mROS in response to MRSA infection, which is required for MRSA killing in phagosomes ( 42 ) . Thus, we hypothesized that neutrophil IRE1α controls NET formation during MRSA infection via production of mROS. To test this hypothesis, we first monitored production of total ROS and mROS by neutrophils during MRSA infection. Total ROS was measured by flow cytometry using CM-H 2 DCFDA probe, which detects many cellular free radical species, and mitochondrial hydrogen peroxide (mH 2 O 2 ), measured by the MitoPY1 probe ( 42 -44 ) . MRSA infection increased both total and mH 2 O 2 at 4h post-infection (pi) (Fig. 2, A and B ). When neutrophils were treated with IRE1α inhibitors or the mROS specific scavenger (NecroX-5), total ROS and mH 2 O 2 production was decreased. Notably, mH 2 O 2 production was profoundly decreased by IRE1α inhibition when compared to total ROS, suggesting that a decrease in total ROS was likely due to decreased mH 2 O 2 production. In addition to increased mH 2 O 2 production, MRSA infection caused reduction in mitochondrial membrane potential, which was rescued by treatment with IRE1α inhibitors or the mROS scavenger, NecroX-5, prior to MRSA infection (Fig. 2C ). We next investigated the role of mROS production in the ability of neutrophils to kill MRSA and form NETs. Treating neutrophils with the mROS scavenger prior to MRSA infection decreased MRSA killing 
IRE1α augments histone citrullination and calcium influx independently of mROS
Histone modification by citrullination is a vital process for NET formation ( 19 ) . In neutrophils, histone citrullination is carried out by the activity of PAD4, which requires intracellular calcium mobilization ( 49 ) . To test whether IRE1α and mROS contribute to MRSA-induced histone citrullination and calcium influx, we assessed induction of histone citrullination during MRSA infection by immunoblot analysis using an antibody specific for the citrullinated form of histone H3. MRSA infection triggered an increase in histone H3 citrullination (Fig. 4A ). Treatment with IRE1α inhibitors prior to infection reduced the level of citrullinated histone H3 compared to untreated neutrophils.
However, treatment with the mROS scavenger, NecroX-5, showed similar levels of histone H3 citrullination compared to DMSO-treated cells (Fig. 4B ). We then monitor higher bacterial counts ( Fig. 5A ) and higher TNFα levels in the abscesses of Casp2 -/mice (Fig. 5B ). This increased level of TNFα in Casp2 -/abscesses may reflect the higher bacterial burden. However, compared to WT mice, Casp2 -/mice had a decreased level of abscess IL-1β ( Fig. 5C ), which is critical for clearance of S.
aureus from a skin and soft-tissue infection model ( 36 ) . Thus, Caspase-2 contributes to IL-1β production and is necessary for S. aureus clearance in a mouse subcutaneous abscess model.
During S. aureus skin infection, NETs are rapidly released by neutrophils to prevent the systemic spread of bacteria ( 8 ) . We next investigated whether NETs could be observed in abscesses in WT and Casp2 -/mice during MRSA infection, using immunofluorescence microscopy. NET formation was assessed by staining abscess histological sections with DAPI to visualize DNA and for the neutrophil marker myeloperoxidase (MPO) (Fig. 5D ). In WT mice, we observed extracellular diffuse DNA associated with MPO, consistent with our observation of NET release in WT neutrophils Collectively, these data suggest that Caspase-2 enhances bacterial clearance by controlling neutrophil NET release in vivo.
Discussion
The IRE1α arm of the ER stress response is integral to development or function of many immune cell types, and has been implicated in many diseases that involve inflammation. Notably, neutrophils can promote inflammatory disease progression and persistence ( 34 , 56 , 57 ) , but the role of IRE1α in neutrophils during inflammatory challenge had not been well studied. Our previous work identified IRE1α as being required for innate immunity in a subcutaneous model of MRSA infection, where neutrophils predominate ( 35 , 36 ) . Our findings here clearly demonstrate that IRE1α is a positive regulator of neutrophil effector function during infection. Activation of IRE1α in neutrophils enhanced production of IL-1β and was required for generation of NETs. We found that inhibition of IRE1α impaired mROS generation, which was needed for CASPASE-2 activation to drive NET formation and IL-1β production ex -vivo and in the subcutaneous abscess. Notably, mROS generation was required for NET formation during sterile inflammation, suggesting a common step regulating NET production in response to both infectious and non-infectious stimuli. Lastly, IRE1α mediated MRSA-induced calcium flux independently of mROS production to activate histone citrullination, a key step in the chromatin decondensation that precedes NET formation ( 13 ) . Our work reveals a central role for the ER stress sensor IRE1α in coordinating neutrophil effector functions.
The ER governs many fundamental processes such as protein synthesis, calcium homeostasis and lipid metabolism that occur in all cells. Our data highlight IRE1α as a key regulator of cell type-specific processes as well. For example, IRE1α enhances the ability of dendritic cells (DCs) to process and present antigen to stimulate T cells ( 58 ) . In the liver, IRE1α signaling enhances hepatic lipogenesis, the process by which dietary carbohydrates are converted into fatty acid-forming triglycerides, independently of its role in the ER stress responses ( 59 ) . In macrophages, IRE1α becomes activated via TLR stimulation augmenting macrophage antimicrobial capacity and production of proinflammatory cytokines ( 31 , 35 ) . Here, we establish a new role for IRE1α in innate immunity in controlling NET formation, a process that occurs uniquely in neutrophils.
These studies emphasize that IRE1α function in particular cell types may encompass both its role in ameliorating ER stress and as an amplifier of signaling, which can impact metabolism and inflammation.
Neutrophils possess lower mitochondrial mass than other cells and mainly rely on glycolysis for ATP production ( 60 ) , thus the contribution of mitochondria to neutrophil function was not historically appreciated. More recent work has demonstrated that neutrophils contain a complex network of mitochondria and that the activity of this organelle augments many essential neutrophil functions including chemotaxis, sustained oxidative stress, NF B signaling, degranulation and apoptosis ( 61 -64 ) .
Additionally, mitochondrial products such as mROS and NAD+ produced through the activity of Complex I are required for NET formation during sterile inflammation and in response to other immune signals ( 17 , 65 ) . Our data show an essential role for mitochondrial function in the response of neutrophils to infectious challenge.
Collectively, our work, together with recent studies, establish mitochondria as a central regulator of neutrophil function.
Calcium release from ER stores serves as a potent stimulatory signal driving immune activation. Neutrophil stimulation with a calcium ionophore increases cytosolic calcium concentration to induce PAD4-dependent histone citrullination and NET formation ( 14 , 20 ) . The upstream signals that initiate calcium flux and PAD4 activation in neutrophils have not been well defined, however, our findings now point to neutrophil IRE1α as a mechanism to control calcium influx and histone citrullination in response to bacterial infection. Of note, while IRE1α mediated calcium flux specifically in response to MRSA infection, IRE1α activation was not required for ionophore-dependent calcium flux.
Calcium can be released from the ER into the cytosol by the activity of the 1,4,5-triphosphate receptor (InsP3R) channels ( 66 ) , and recent work has implicated InsP3R channels as a mechanism by which IRE1α can mediate flux ( 67 ) . In that case, IRE1α acted as a scaffold independently of its enzymatic activity to concentrate InsP3R channels at ER-mitochondria contact sites to facilitate calcium release. However, our data suggest that IRE1α endonuclease activity is required for calcium flux during MRSA infection, since an inhibitor of the endonuclease domain prevented calcium flux and NETosis. Thus, IRE1α may control calcium flux through multiple mechanisms in a context-dependent manner.
Targeting IRE1α activity with small molecule inhibitors represents a potential therapeutic strategy for treating inflammatory diseases. However, our data show that IRE1α augments host defense against bacterial challenge and its inhibition could inadvertently increase susceptibility to microbial infection ( 31 , 35 ) . Some evidence in murine models of inflammatory disease, such as rheumatoid arthritis or atherosclerosis, suggests that IRE1α inhibition can counteract the progression of chronic inflammation ( 33 , 70 , 71 ) .
Because IRE1α contributes to a range of cellular outcomes, such as cell survival, cell death and inflammation, inhibition of its activity could impact different diseases through diverse mechanisms. In an experimental arthritis mouse model, IRE1α inhibition with 4 8C attenuated joint inflammation by decreasing production of proinflammatory cytokines such as IL-1β, IL-6, and TNF-α ( 71 ) . Together, these studies support the investigation of IRE1α inhibitors as possible treatments in human disease. However, our work and others have demonstrated that the IRE1α arm of the unfolded protein response contributes to immunity against bacterial infection ( 31 , 35 ) . Thus, further exploration of the specific mechanisms by which IRE1α controls immunity and inflammation will provide needed molecular context for effective therapeutic strategies. Statistical Analysis. Data were statistically analyzed and graphed using Graphpad Prism 7. Differences between the 2 groups were tested using the Mann-Whitney Test.
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Differences between 3 or more groups were tested using One-way ANOVA and 
